ESR1 and breast cancer: However, depletion of circPVT1 was demonstrated to restrain BC cell growth and resensitize tamoxifen-resistant MCF7 cells to tamoxifen therapy, suggesting that circPVT1 could act as a promising target for ERα-positive BC therapy clinically [94].